Works (10)

2019 journal article

Evaluation of the Tolerability of Combination Chemotherapy with Mitoxantrone and Dacarbazine in Dogs with Lymphoma

JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 55(2), 101–109.

By: J. Intile, K. Rassnick, R. Al-Sarraf & J. Chretin

Sources: NC State University Libraries, ORCID
Added: March 4, 2019

2019 article

Prognostic and predictive significance of KIT protein expression and c-kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology-Pathology Working Group

VETERINARY AND COMPARATIVE ONCOLOGY.

By: D. Thamm, A. Avery, D. Berlato, J. Bulman-Fleming, C. Clifford, A. Hershey, J. Intile, P. Jones ...

Sources: Web Of Science, ORCID
Added: August 12, 2019

2018 journal article

Dogs with acute myeloid leukemia or lymphoid neoplasms (large cell lymphoma or acute lymphoblastic leukemia) may have indistinguishable mediastinal masses on radiographs

VETERINARY RADIOLOGY & ULTRASOUND, 59(5), 507–515.

By: E. Epperly, K. Hume, S. Moirano, T. Stokol, J. Intile, H. Erb, P. Scrivani

Sources: NC State University Libraries, ORCID
Added: October 16, 2018

2014 journal article

Tolerability of Lomustine in Combination with Cyclophosphamide in Dogs with Lymphoma

Journal of the American Animal Hospital Association, 50(3), 167–173.

By: K. Rassnick, D. Bailey, E. Malone, A. Flory, M. Kiselow & J. Intile

Sources: Crossref, ORCID
Added: November 16, 2019

2010 journal article

A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours

Veterinary and Comparative Oncology, 8(2), 138–152.

By: K. Rassnick, D. Bailey, D. Russell, A. Flory, M. Kiselow, J. Intile, E. Malone, C. Balkman, S. Barnard

Sources: Crossref, ORCID
Added: November 16, 2019

2010 journal article

Comparison between l-CHOP and an l-CHOP protocol with interposed treatments of CCNU and MOPP (l-CHOP-CCNU-MOPP) for lymphoma in dogs

Veterinary and Comparative Oncology, 8(4), 243–253.

By: K. Rassnick, D. Bailey, E. Malone, J. Intile, M. Kiselow, A. Flory, L. Barlow, C. Balkman ...

Sources: Crossref, ORCID
Added: November 16, 2019

2010 journal article

Phase II, Open-Label Trial of Single-Agent CCNU in Dogs with Previously Untreated Histiocytic Sarcoma

Journal of Veterinary Internal Medicine, 24(6), 1528–1531.

By: K. Rassnick, A. Moore, D. Russell, N. Northrup, O. Kristal, D. Bailey, A. Flory, M. Kiselow, J. Intile

Sources: Crossref, ORCID
Added: November 16, 2019

2009 journal article

Evaluation of dexamethasone as a chemoprotectant for CCNU-induced bone marrow suppression in dogs

Veterinary and Comparative Oncology, 7(1), 69–77.

By: J. Intile, K. Rassnick, D. Bailey, R. Al-Sarraf, J. Chretin, C. Balkman, A. Flory, M. Kiselow, J. Wakshlag

Sources: Crossref, ORCID
Added: November 16, 2019

2008 journal article

Efficacy of Vinblastine for Treatment of Canine Mast Cell Tumors

Journal of Veterinary Internal Medicine, 22(6), 1390–1396.

By: K. Rassnick, D. Bailey, A. Flory, C. Balkman, M. Kiselow, J. Intile, K. Autio

Sources: Crossref, ORCID
Added: November 16, 2019

2001 journal article

A mechanism for combinatorial regulation of electrical activity: Potassium channel subunits capable of functioning as Src homology 3-dependent adaptors

Proceedings of the National Academy of Sciences, 98(2), 705–710.

By: M. Nitabach, D. Llamas, R. Araneda, J. Intile, I. Thompson, Y. Zhou, T. Holmes

Sources: Crossref, ORCID
Added: November 16, 2019